MedTrace Logo

Clinical Trial in Patients With Metastatic Colorectal Cancer

NCT00081627 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2007-11-27

No results posted yet for this study

Summary

The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.

Conditions

Interventions

DRUG

CoFactor and 5FU

Sponsors & Collaborators

Principal Investigators

  • Tony Reid, MD, PhD · University of California, San Diego

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-04-30
Completion
2007-01-31

Countries

  • United States
  • Serbia and Montenegro

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00081627 on ClinicalTrials.gov